Childhood cancers trials in New Zealand
27 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleDinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Where
- Grafton
- Age
- Up to 30 years
- People
- 478 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06172296 - Phase 2Taking peopleACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Where
- Auckland
- Age
- 12 months to 39 years
- People
- 60 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT06838676 - Phase 3Taking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Auckland, Christchurch
- Age
- 1 day to 1 year
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - Phase 2Taking peopleA Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
- Where
- Christchurch, Grafton
- Age
- Up to 21 years
- People
- 50 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06064097 - Phase 2/3Taking peopleSafety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Where
- Auckland, Christchurch
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00 - Phase 2Taking peopleA Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
- Where
- Christchurch
- Age
- 3 years to 29 years
- People
- 160 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT04684368 - No phaseTaking peopleTargeted Pediatric High-Grade Glioma Therapy
- Where
- Auckland
- Age
- 12 months to 39 years
- People
- 350 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05839379 - Phase 2/3Taking peopleAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Auckland
- Age
- 1 month to 18 years
- People
- 1,800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - Phase 3Taking peopleAccelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
- Where
- Christchurch, Dunedin, Grafton, Roslyn
- Age
- 11 years to 50 years
- People
- 500 worldwide
- Run by
- University of Sydney
See details and how to joinNCT02582697 - Phase 2Taking peopleStudy of Olutasidenib and Temozolomide in HGG
- Where
- Auckland
- Age
- 12 years to 39 years
- People
- 60 worldwide
- Run by
- Rigel Pharmaceuticals
See details and how to joinNCT06161974 - No phaseTaking peopleProject: Every Child for Younger Patients With Cancer
- Where
- Christchurch, Grafton
- Age
- Up to 25 years
- People
- 75,000 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT02402244 - Phase 3Taking peopleActive Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Where
- Christchurch, Grafton
- People
- 1,780 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT03067181 - Phase 3Taking peopleInotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Where
- Christchurch, Grafton
- Age
- 365 days to 25 years
- People
- 5,951 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT03959085 - Phase 2Taking peopleA Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- Where
- Christchurch, Grafton
- Age
- Up to 30 years
- People
- 256 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT04322318 - Phase 1/2Taking peopleThe Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Where
- Christchurch, Grafton
- Age
- Up to 22 years
- People
- 960 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT04726241 - Phase 3Taking peopleThoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Where
- Christchurch, Grafton
- Age
- Up to 50 years
- People
- 62 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05235165 - Phase 3Taking peopleChemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
- Where
- Christchurch, Grafton
- Age
- Up to 21 years
- People
- 205 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05304585 - Phase 3Taking peopleA Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
- Where
- Christchurch, Grafton
- Age
- Up to 30 years
- People
- 1,656 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT06401330 - Phase 3Taking peopleBrentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Where
- Auckland
- Age
- 16 years to 69 years
- People
- 1,042 worldwide
- Run by
- University College, London
See details and how to joinNCT04685616 · EU 2022-500031-37-00 - Early phase 1Taking peopleLorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Where
- Auckland
- Age
- 1 year to 21 years
- People
- 15 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT06333899 - Phase 2Taking peopleCombination Therapy for the Treatment of Diffuse Midline Gliomas
- Where
- Auckland
- Age
- 2 years to 39 years
- People
- 360 worldwide
- Run by
- University of California, San Francisco
See details and how to joinNCT05009992 · EU 2023-507598-16-00 - Phase 2Taking peopleStudy of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Where
- Auckland
- Age
- 12 months to 39 years
- People
- 120 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05843253 - Early phase 1Taking peopleA Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Where
- Auckland
- Age
- Up to 21 years
- People
- 15 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT04655404 · EU 2023-508953-16-00 - Phase 2/3Taking peopleA Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
- Where
- Auckland
- Age
- Up to 25 years
- People
- 210 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT05991388 · EU 2024-510575-38-00 - Phase 1/2Taking peopleA Multi-Arm, Platform Trial For Relapsed Neuroblastoma
- Where
- Auckland
- Age
- 1 year to 64 years
- People
- 160 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT07334301 · EU 2024-516115-24-00